KRX extends Gene One Life Science listing review committee deadline to Oct. 30, trade suspension continues
Bitget2026/09/28 08:57- KRX extended the deadline to convene a listing review committee for Gene One Life Science to Oct. 30, 2026.
- The review follows a substantive listing-eligibility examination triggered by a July 16, 2026 disclosure of a major management matter.
- Trading in the company’s shares will remain suspended until a decision on continued listing eligibility is reached.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
$6.2 million, a whale withdrew 39,018 AAVE from an exchange
Synopsys (SNPS.US) partners with OpenAI to develop AI models for chip design, revenue-sharing model drives stock price up by 7%
On Wednesday, chip design software provider Synopsys (SNPS.US) announced that it has reached a partnership agreement with OpenAI. Both parties will jointly develop AI models for the chip business and share related revenues.
BoJ Summary of Opinions: Member says appropriate to keep raising rates in line with economy, price
Rio Tinto secures Bell Bay aluminum smelter operations till 2031
Crypto prices
More
